Millipore Sigma Vibrant Logo

445874 mGluR5 Antagonist, MTEP - CAS 329205-68-7 - Calbiochem

The mGluR5 Antagonist, MTEP, also referenced under CAS 329205-68-7, controls the biological activity of mGluR5. This small molecule/inhibitor is primarily used for Neuroscience applications.

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: 3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine

Primary Target: mGluR5
View Products on Sigmaaldrich.com
445874
View Pricing & Availability

Overview

Replacement Information

Key Spec Table

CAS #Empirical Formula
329205-68-7C₁₁H₈N₂S

Pricing & Availability

Catalogue Number AvailabilityPackaging Qty/Pack Price Quantity
445874-5MG
Retrieving availability...
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Plastic ampoule 5 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      Description
      OverviewA brain-permeable (thiazole-pyridine)alkyne compound that acts as a potent, selective and non-competitive mGluR5 (metabotropic glutamate receptor subtype-5) antagonist (IC50 = 5 nM in Ca2+-flux assay; Ki = 16 nM) with in vivo anxiolytic activity in a rodent model (ED50 = 1 mg/kg, ip and 7 mg/kg, po). Devoid of any side effects seen with MPEP and benzodiazepines. Reported to weakly affect the activities of other enzymes and receptors tested (IC50 = 30 µM for MAO-A, > 100 µM for mGlu1R, 2R & 7R, and > 300 µM for NR2BR).
      Catalogue Number445874
      Brand Family Calbiochem®
      Synonyms3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine
      References
      ReferencesBradbury, M.J., et al. 2005. J. Pharmacol. Exp. Ther. 313, 395.
      Busse, C.S., et al. 2004. Neuropsychopharmacology 29, 1971.
      Roppe, J.R., et al. 2004. Bioorg. Med. Chem. Lett. 14, 3993.
      Klodzinska, A., et al. 2004. Neuropharmacology 47, 342.
      Cosford, N.D.P., et al. 2003. J. Med. Chem. 46, 204.
      Brodkin, J., et al. 2002. Eur. J. Neurosci. 16, 2241.
      Product Information
      CAS number329205-68-7
      ATP CompetitiveN
      FormWhite to yellow solid
      Hill FormulaC₁₁H₈N₂S
      Chemical formulaC₁₁H₈N₂S
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetmGluR5
      Primary Target IC<sub>50</sub>5 nM in Ca2+-flux assay
      Primary Target K<sub>i</sub>16 nM for mGluR5 (metabotropic glutamate receptor subtype-5)
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      445874-5MG 04055977204629

      Documentation

      mGluR5 Antagonist, MTEP - CAS 329205-68-7 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      mGluR5 Antagonist, MTEP - CAS 329205-68-7 - Calbiochem Certificates of Analysis

      TitleLot Number
      445874

      References

      Reference overview
      Bradbury, M.J., et al. 2005. J. Pharmacol. Exp. Ther. 313, 395.
      Busse, C.S., et al. 2004. Neuropsychopharmacology 29, 1971.
      Roppe, J.R., et al. 2004. Bioorg. Med. Chem. Lett. 14, 3993.
      Klodzinska, A., et al. 2004. Neuropharmacology 47, 342.
      Cosford, N.D.P., et al. 2003. J. Med. Chem. 46, 204.
      Brodkin, J., et al. 2002. Eur. J. Neurosci. 16, 2241.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision19-June-2018 JSW
      Synonyms3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine
      DescriptionA brain-permeable (thiazole-pyridine)alkyne compound that acts as a potent, selective and non-competitive mGluR5 (metabotropic glutamate receptor subtype-5) antagonist (IC50 = 5 nM in Ca2+-flux assay; Ki = 16 nM) with in vivo anxiolytic activity in a rodent model (ED50 = 1 mg/kg, ip and 7 mg/kg, po). Devoid of any side effects seen with MPEP and benzodiazepines. Reported to weakly affect the activities of other enzymes and receptors tested (IC50 = 30 µM for MAO-A, >100 µM for mGlu1R, 2R & 7R, and >300 µM for NR2BR).
      FormWhite to yellow solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number329205-68-7
      Chemical formulaC₁₁H₈N₂S
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (5 mg/ml) or Methanol (1 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesBradbury, M.J., et al. 2005. J. Pharmacol. Exp. Ther. 313, 395.
      Busse, C.S., et al. 2004. Neuropsychopharmacology 29, 1971.
      Roppe, J.R., et al. 2004. Bioorg. Med. Chem. Lett. 14, 3993.
      Klodzinska, A., et al. 2004. Neuropharmacology 47, 342.
      Cosford, N.D.P., et al. 2003. J. Med. Chem. 46, 204.
      Brodkin, J., et al. 2002. Eur. J. Neurosci. 16, 2241.